Delivery Order SPE2DB24D2003-SPE2DB25FXHL9
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.62 firm-fixed-price delivery order is for the supply of 4,567,927,138 units of the medication Ondansetron ODT 8 mg Tablet. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,493.29 delivery order contract is for the supply of 4,567,977,353 units of the medication Ondansetron ODT 8 mg tablet. The contract is a firm fixed-price, non-set-aside award with a performance period through April 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 8 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $2,402.37 and a performance period through March 19, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This $2,937.13 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,881,074 units of the drug Ondansetron ODT 4 mg tablets in 30-count packages. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $27,519.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,060,760 units of the medication Ondansetron ODT 8 mg tablet, with a performance period ending on April 29, 2025. This contract is a delivery order and is priced on a firm-fixed-price basis. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,481.96 firm fixed-price delivery order is for the supply of 4,568,158,580 units of the medication Ondansetron ODT 4 mg Tablet. The contract is not set aside and has a period of performance through May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.54 contract is for the delivery of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. This IDC allows the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $1,213.45 contract is to provide 4564158498 - Ondansetron ODT 8 mg tablets in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to deliver pharmaceuticals...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $12,270.91 firm fixed price delivery order is for the supply of 4,565,827,961 units of the prescription medication Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,352.98, is a delivery order for the supply of 4,567,926,368 units of the medication Ondansetron ODT 8 mg Tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...